Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $205.38 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $160.13 | 14 | $0 (2022) |
| AbbVie Inc. | $32.04 | 2 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $13.21 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $84.45 | 8 | Sunovion Pharmaceuticals Inc. ($84.45) |
| 2021 | $32.04 | 2 | AbbVie Inc. ($32.04) |
| 2019 | $88.89 | 7 | Sunovion Pharmaceuticals Inc. ($75.68) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: CNS | ||||||
| 09/27/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: CNS | ||||||
| 08/24/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: CNS | ||||||
| 08/16/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $7.33 | General |
| Category: CNS | ||||||
| 06/01/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $5.15 | General |
| Category: CNS | ||||||
| 03/23/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $5.76 | General |
| Category: CNS | ||||||
| 01/20/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: CNS | ||||||
| 01/11/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: CNS | ||||||
| 05/26/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: NEUROSCIENCE | ||||||
| 04/28/2021 | AbbVie Inc. | VIIBRYD (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: CNS | ||||||
| 10/02/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $2.33 | General |
| Category: CNS | ||||||
| 07/31/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $4.72 | General |
| Category: CNS | ||||||
| 06/11/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: CNS | ||||||
| 05/20/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: CNS | ||||||
| 04/16/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: CNS | ||||||
| 01/28/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 510 | 2,282 | $313,675 | $176,813 |
| 2022 | 13 | 626 | 2,538 | $338,765 | $163,913 |
| 2021 | 11 | 548 | 1,857 | $221,230 | $119,066 |
| 2020 | 7 | 544 | 2,039 | $245,160 | $127,920 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 29 | 781 | $117,150 | $68,428 | 58.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 54 | 233 | $38,445 | $24,092 | 62.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 54 | 364 | $47,320 | $23,420 | 49.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 87 | 180 | $28,800 | $17,159 | 59.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 55 | 248 | $22,320 | $13,204 | 59.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2023 | 41 | 210 | $18,900 | $10,448 | 55.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 102 | $15,300 | $6,505 | 42.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 43 | 49 | $9,800 | $5,067 | 51.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 41 | 45 | $7,200 | $4,212 | 58.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $4,200 | $2,583 | 61.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 27 | $2,700 | $1,284 | 47.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 22 | 22 | $1,540 | $412.59 | 26.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2022 | 106 | 707 | $63,630 | $36,503 | 57.4% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 27 | 415 | $82,270 | $30,646 | 37.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 76 | 504 | $65,520 | $29,272 | 44.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 104 | 227 | $36,320 | $18,606 | 51.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 47 | 259 | $23,325 | $13,746 | 58.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 108 | $17,820 | $10,369 | 58.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 33 | 102 | $15,300 | $7,036 | 46.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 57 | 61 | $12,200 | $6,573 | 53.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 41 | 43 | $6,880 | $3,626 | 52.7% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 24 | 25 | $5,340 | $2,575 | 48.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $3,200 | $2,172 | 67.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 11 | 14 | $2,100 | $1,223 | 58.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 22 | 29 | $2,900 | $1,114 | 38.4% |
About Dr. Muhammad Uddin, M.D
Dr. Muhammad Uddin, M.D is a Psychiatry healthcare provider based in Roseville, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1972709798.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muhammad Uddin, M.D has received a total of $205.38 in payments from pharmaceutical and medical device companies, with $84.45 received in 2022. These payments were reported across 17 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($205.38).
As a Medicare-enrolled provider, Uddin has provided services to 2,228 Medicare beneficiaries, totaling 8,716 services with total Medicare billing of $587,712. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Roseville, CA
- Active Since 06/27/2007
- Last Updated 07/20/2016
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1972709798
Products in Payments
- LATUDA (Drug) $160.13
- VRAYLAR (Drug) $20.76
- INVEGA SUSTENNA (Drug) $13.21
- VIIBRYD (Drug) $11.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Roseville
James Adamo, M.d, M.D
Psychiatry — Payments: $25,855
Jonathon Porter, D.o, D.O
Psychiatry — Payments: $4,935
Dr. Prudencio Samson, Md, MD
Psychiatry — Payments: $4,745
Lorerky Ramirez-Moya, Md, MD
Psychiatry — Payments: $3,832
Dr. Karla De Beck, M.d, M.D
Psychiatry — Payments: $2,982
Chunlin Yang, M.d, M.D
Psychiatry — Payments: $2,557